Evidence map›Paper›PMID 33742432›Full record

ReviewSeminars in neurology2021

Evidence for Early and Regular Physical Therapy and Exercise in Parkinson's Disease.

Terry D Ellis, Cristina Colón-Semenza, Tamara R DeAngelis, Cathi A Thomas, Marie-Hélène Saint Hilaire, Gammon M Earhart, Leland E Dibble

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 4 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 4 syntheses or guidelines pooled it, 157 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Physical Activity and Exercise for People with Parkinson's Disease: The Past, Present, and Future.Movement disorders : official journal of the Movement Disorder Society · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Organosulfur Compounds: Potential Therapeutics for Parkinson's Disease.CNS & neurological disorders drug targets · 2026
    Review
  19. Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Terry D EllisDepartment of Physical Therapy and Athletic Training, College of Health and Rehabilitation Sciences: Sargent College, Boston University, Boston, Massachusetts.
Cristina Colón-SemenzaCenter for Neurorehabilitation, College of Health and Rehabilitation Sciences: Sargent College, Boston University, Boston, Massachusetts.
Tamara R DeAngelisCenter for Neurorehabilitation, College of Health and Rehabilitation Sciences: Sargent College, Boston University, Boston, Massachusetts.
Cathi A ThomasParkinson's Disease and Movement Disorders Center, Boston University Medical Campus, Boston, Massachusetts.
Marie-Hélène Saint HilaireParkinson's Disease and Movement Disorders Center, Boston University Medical Campus, Boston, Massachusetts.
Gammon M EarhartProgram in Physical Therapy, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Leland E DibbleDepartment of Physical Therapy and Athletic Training, The University of Utah, Salt Lake City, Utah.
Boston University · USBoston Medical Center · USUniversity of Utah · USWashington University in St. Louis · US

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Walking and mHealth to Increase Participation in Parkinson Disease (WHIP-PD)R01HD092444 · NICHD · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI EARHART, GAMMON M., ELLIS, THERESA · 2018 to 2022
$3.2M
NCATS NIH HHS UL1 TR002538NICHD NIH HHS R01 HD092444
6 · The paper itself

Abstract

Advances in medical management of Parkinson's disease (PD) have resulted in living longer with disability. Although disability worsens over the course of the disease, there are signs of disability even in the early stages. Several studies reveal an early decline in gait and balance and a high prevalence of nonmotor signs in the prodromal period that contribute to early disability. There is a growing body of evidence revealing the benefits of physical therapy and exercise to mitigate motor and nonmotor signs while improving physical function and reducing disability. The presence of early disability coupled with the benefits of exercise suggests that physical therapy should be initiated earlier in the disease. In this review, we present the evidence revealing early disability in PD and the effectiveness of physical therapy and exercise, followed by a discussion of a secondary prevention model of rehabilitation to reduce early disability and optimize long-term outcomes.

Indexed as

Parkinson DiseaseActivities of Daily LivingExercise TherapyGaitHumansPhysical Therapy ModalitiesSecondary Prevention

Identifiers

PMID33742432
PMCPMC8678920
OpenAlexW3136300530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.